Pre-clinical Models of Pancreatic Ductal Adenocarcinoma

Hwang, C. I., Boj, S. F., Clevers, H., Tuveson, D. A. (2016) Pre-clinical Models of Pancreatic Ductal Adenocarcinoma. J Pathol, 238 (2). pp. 197-204. ISSN 1096-9896 (Electronic)0022-3417 (Linking)

URL: http://www.ncbi.nlm.nih.gov/pubmed/26419819
DOI: 10.1002/path.4651

Abstract

Pancreatic ductal adenocarcinoma (PDA) is one of the most difficult human malignancies to treat. Five-year survival rate of PDA patients is 7%, and PDA is predicted to become the second leading cancer-related cause of death in the United States of America. Despite intensive efforts, the translation of findings in preclinical studies has been ineffective, due partially to the lack of preclinical models that faithfully recapitulate features of human PDA. Here we review current preclinical models for human PDA (e.g. human PDA cell lines, cell line-based xenografts and patient-derived tumor xenografts). In addition, we discuss potential applications of the recently developed pancreatic ductal organoids, three-dimensional culture systems and organoid-based xenografts as new preclinical models for PDA.

Item Type: Paper
Uncontrolled Keywords: Pancreatic cancer organoid patient-derived tumor xenograft preclinical model
Subjects: organism description > model organism
diseases & disorders > cancer > cancer types > pancreatic cancer
CSHL Authors:
Communities: CSHL labs > Tuveson lab
CSHL Cancer Center Program > Signal Transduction
Depositing User: Matt Covey
Date Deposited: 01 Oct 2015 21:37
Last Modified: 05 Mar 2018 15:43
PMCID: PMC4700534
Related URLs:
URI: http://repository.cshl.edu/id/eprint/31907

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving